Legal & Disputes
Pomerantz LLP Opens Securities Fraud Investigation Into Applied Aerospace & Defense After Guidance Cut
By News Desk ·
Key takeaways
- Pomerantz LLP is investigating whether Applied Aerospace & Defense and its officers engaged in securities fraud or other unlawful business practices.
- Applied lowered its full-year 2026 revenue outlook to a range of $660 million to $670 million and projected Adjusted EBITDA of $137 million to $142 million.
- Applied's stock fell 13.25% to $9.30 per share on November 11, 2026, and 18.74% to $6.81 per share on November 16, 2026, after Jefferies downgraded the stock from Buy to Hold.
Pomerantz LLP is investigating claims on behalf of investors of Applied Aerospace & Defense, Inc. over whether the company and certain officers or directors engaged in securities fraud or other unlawful business practices, the firm said in a PR Newswire announcement on November 19, 2026. Investors are advised to contact Danielle Peyton.
Applied's Guidance Cut and Stock Decline
Applied Aerospace & Defense conducted its initial public offering on or around June 2, 2026, selling 32.5 million shares of common stock priced at $20.00. On November 11, 2026, the company reported financial results for the third quarter ended September 30, 2026, and issued full-year 2026 guidance.
Despite reporting quarterly revenue growth, Applied lowered its full-year 2026 revenue outlook to a range of $660 million to $670 million, below analyst consensus estimates, and projected full-year Adjusted EBITDA of $137 million to $142 million. Management disclosed that supplier constraints in specialized forgings, castings, and fasteners, along with delayed government regulatory approvals for Apache helicopter rotor head overhauls, had forced the company to push approximately $15 million to $20 million of high-margin rotorcraft aftermarket revenue out of the fourth quarter of 2026 and into the first half of 2027.
Applied also reported that its consolidated gross profit margin compressed to 23.5% from 28.0% in the prior-year period due to program ramp costs and operational inefficiencies, while free cash flow turned negative at -$9.5 million. On this news, Applied's stock price fell $1.42 per share, or 13.25%, to close at $9.30 per share on November 11, 2026, on heavy trading volume.
On November 16, 2026, Jefferies Financial Group downgraded Applied from "Buy" to "Hold", citing trimmed 2026 guidance, pushed-out margins, and component delivery delays. Following the downgrade, Applied's stock price fell $1.57 per share, or 18.74%, to close at $6.81 per share on November 16, 2026.
Pomerantz's Litigation Record
Pomerantz LLP is a plaintiff-side securities litigation law firm founded in 1936 that represents investors in securities class actions, corporate governance cases, and global investor recovery proceedings across six offices in the U.S., U.K., France, and Israel, according to akta.pro company records. The firm's historic recoveries include $3 billion for investors in the Petrobras securities litigation, $350 million for investors in United Healthcare, and $225 million for investors in Comverse Technology, Inc., the same records show.
Earlier Pomerantz Investor Alerts
Pomerantz announced a proposed class action settlement for purchasers of Gritstone bio securities on September 28, 2026, with a hearing set for December 4, 2026 and a settlement fund totaling $6 million, PR Newswire reported. On September 1, 2026, the firm announced a class action lawsuit against Taboola.com Ltd. over alleged securities fraud, FinancialContent Business Page reported. Pomerantz announced on August 25, 2026 that a class action lawsuit had been filed against GPGI, Inc. alleging securities fraud or unlawful business practices by the company and certain officers or directors, FinancialContent Business Page reported.
Next Steps for Pomerantz LLP
Pomerantz's investigation follows Applied's November 11, 2026 guidance and the November 16, 2026 Jefferies downgrade. Investors with losses in Applied are advised to contact Danielle Peyton at Pomerantz.